Geisinger Medical Laboratories Test Catalog
CULTURE, NOCARDIA |
||
Geisinger Epic Procedure Code: LAB2139
Geisinger Epic ID: 35226
|
||
SPECIMEN COLLECTION |
||
Specimen type: |
Body fluids, bone, respiratory secretions, tissue, wounds | |
Preferred collection container: |
||
Specimen required: |
Fluids: 5-10 mL; minimum 1 ml. Tissues: 0.5-1 cm diameter (pea size); minimum 0.2 cm diameter (rice grain). | |
Special notes: |
Preferred swab collection device is the ESwab. Sterile specimen container, anaerobic transport media (ATM), collection trap, C&S preservative tube, BD CultureSwab, BD CultureSwab Plus, Health Link Transport Sterile Liquid Stuart, Amies or Stuarts Liquid Stuarts Swabs, and Amies Gel Swabs are also acceptable. A Gram stain will be performed on most clinical specimens when possible. See Microbiology Collection Appendix for collection instructions. Check expiration date on transport device before use. | |
SPECIMEN PROCESSING |
||
Transport temperature: |
Room temperature (18-25°C) | |
Specimen stability: |
Approved swab: Room temperature 72 hours Specimen in ATM: Room temperature 72 hours Sterile container: Room temperature or 2-8°C 24 hours |
|
Rejection criteria: |
Improperly labeled/identified specimen. Expired collection/transport device. Quantity of specimen insufficient. Frozen specimens. Specimens in formalin. Delay in transport. | |
TEST DETAILS |
||
Reference interval: |
No aerobic actinomycetes isolated | |
Critical values/courtesy alerts: |
Specific aerobic actinomycete isolate | |
CPT code(s): |
87205, 87081 | |
Note: The billing party has sole responsibility for CPT coding. Any questions regarding coding should be directed to the payer being billed. The CPT codes provided by GML are based on AMA guidelines and are for informational purposes only. | ||
Test includes: |
Isolation and identification of aerobic actinomycetes. Additional charges may apply. | |
Methodology: |
Culture Smear |
|
Synonyms: |
Aerobic actinomycete, actinomycete culture, nocardia; nocardia smear and culture NCRD
|
|
Clinical significance: |
Detection and identification of aerobic actinomycetes can assist in the determination of clinical disease and guide appropriate therapy when required | |
Doctoral Director(s:) |
Donna Wolk PhD, D(ABMM), Raquel Martinez, PhD, D(ABMM) | |
Review Date: | 12/31/2022 |